Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability
- PMID: 17960872
- DOI: 10.1021/bc0603889
Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability
Abstract
Improving the oral bioavailability of therapeutic compounds remains a challenging area of research. Polyamidoamine (PAMAM) dendrimers are promising candidates for oral drug delivery due to their well-defined compact structure, versatility of surface functionalities, low polydispersity, and ability to enhance transepithelial transport. However, potential cytotoxicity has hampered the development of PAMAM dendrimers for in vivo applications. In this article, we have systematically modified the surface groups of amine-terminated PAMAM dendrimers with acetyl groups. The effect of this modification on cytotoxicity, permeability, and cellular uptake was investigated on Caco-2 cell monolayers. Cytotoxicity was reduced by more than 10-fold as the number of surface acetyl groups increased while maintaining permeability across the cell monolayers. Furthermore, a decrease in nonspecific binding was evident for surface-modified dendrimers compared to their unmodified counterparts. These studies point to novel strategies for minimizing PAMAM dendrimer toxicity while maximizing their transepithelial permeability.
Similar articles
-
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.Expert Opin Drug Deliv. 2009 Aug;6(8):835-50. doi: 10.1517/17425240903061251. Expert Opin Drug Deliv. 2009. PMID: 19637972 Review.
-
Studies on polyamidoamine dendrimers as efficient gene delivery vector.J Biomater Appl. 2008 May;22(6):527-44. doi: 10.1177/0885328207080005. Epub 2007 Jul 10. J Biomater Appl. 2008. PMID: 17623709
-
In vitro evaluation of dendrimer prodrugs for oral drug delivery.Int J Pharm. 2007 May 4;336(1):183-90. doi: 10.1016/j.ijpharm.2006.11.047. Epub 2006 Nov 28. Int J Pharm. 2007. PMID: 17188439
-
Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.Bioconjug Chem. 2007 Nov-Dec;18(6):2068-76. doi: 10.1021/bc070116l. Epub 2007 Sep 12. Bioconjug Chem. 2007. PMID: 17848077
-
Transepithelial and endothelial transport of poly (amidoamine) dendrimers.Adv Drug Deliv Rev. 2005 Dec 14;57(15):2163-76. doi: 10.1016/j.addr.2005.09.013. Epub 2005 Nov 11. Adv Drug Deliv Rev. 2005. PMID: 16289433 Review.
Cited by
-
Dendrimers as Modulators of Brain Cells.Molecules. 2020 Sep 30;25(19):4489. doi: 10.3390/molecules25194489. Molecules. 2020. PMID: 33007959 Free PMC article. Review.
-
Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy.Colloids Surf B Biointerfaces. 2015 Feb 1;126:590-597. doi: 10.1016/j.colsurfb.2014.12.042. Epub 2015 Jan 3. Colloids Surf B Biointerfaces. 2015. PMID: 25591850 Free PMC article.
-
Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.Biomacromolecules. 2014 Aug 11;15(8):2889-95. doi: 10.1021/bm5004465. Epub 2014 Jul 3. Biomacromolecules. 2014. PMID: 24992090 Free PMC article.
-
Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.Bioconjug Chem. 2008 Aug;19(8):1660-72. doi: 10.1021/bc700483s. Epub 2008 Jul 9. Bioconjug Chem. 2008. PMID: 18610944 Free PMC article.
-
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.Adv Drug Deliv Rev. 2012 May 1;64(6):571-88. doi: 10.1016/j.addr.2011.09.010. Epub 2011 Sep 29. Adv Drug Deliv Rev. 2012. PMID: 21983078 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources